Collectively, our results suggest that the altered endocrine hormones like increased FSH rather than mere increased visceral adipose deposition may play a more important role in promoting the development of metabolic abnormalities, including dyslipidemia, hepatic steatosis, and insulin resistance in estrogen-depleted females. The gene discussed is BRD2; the disease is Hepatic steatosis.